Mitosense is a biotechnology company developing treatments for neurodegenerative diseases.
Mitosense has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Mitosense's investors include Caydan Capital Partners.
Mitosense is headquartered in Great Falls, United States.
Mitosense is a biotechnology company developing treatments for neurodegenerative diseases.
Mitosense is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mitosense — Funding & Investors." VCBacked, January 22, 2024, https://www.vcbacked.co/company/mitosense. Accessed October 3, 2026.
VCBacked. (2024). Mitosense — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/mitosense
{{cite web |title=Mitosense — Funding & Investors |url=https://www.vcbacked.co/company/mitosense |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated